483 Naveed Razzaque, M.D. Sep 2019
FDA investigators audited the Naveed Razzaque, M.D. - Bridgeton, MO, United States facility and issued inspectional observations (via FDA 483) on 25 Sep 2019.
- Category: Human Drugs
- Inspection end: 25 Sep 2019
- Location: Bridgeton, United States
- FEI: 3015651362
No 483 recorded for this inspection.